July 14, 2026

Silo Pharma’s QwikAgents joins AMD AI Developer Program for enhanced resources

Silo Pharma announced that its QwikAgents platform has joined the AMD AI Developer Program, granting it access to AMD Developer Cloud credits, AI tools, and technical resources. This move is part of QwikAgents’ initiative to expand its AI agent capabilities through partnerships with major technology developer programs, aligning with AMD’s offerings that provide specialized cloud resources and technical support for advancing enterprise AI applications.

AMD: AMD is a semiconductor company that develops high-performance computing and AI technologies, including processors and accelerators. It operates the AMD AI Developer Program to provide developers with cloud credits, tools, training, and community support for building on its platforms. QwikAgents’ enrollment grants Silo Pharma’s AI platform direct access to these AMD resources for enhanced development.
Silo Pharma: Silo Pharma is a developmental-stage biopharmaceutical company focused on treatments for underserved conditions including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases. Its wholly owned subsidiary QwikAgents develops an enterprise AI agent integration platform for workflow automation. The company announced QwikAgents’ participation in the AMD AI Developer Program to leverage AI tools and technical resources for platform advancement.

`json
{
“AI Development”: “AMD’s AI Developer Program offers participating platforms access to specialized cloud resources and technical support for advancing AI applications.”,
“Platform Expansion”: “QwikAgents is extending its capabilities through participation in major technology developer programs.”
}
`

AI tools built by Emerald Force

Built and supported by Emerald Force.

You might also like